MLAB Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.…
Industry Peers
Scientific & Technical InstrumentsKey Statistics
About Mesa Laboratories (NASDAQ: MLAB)
›
Mesa Laboratories (NASDAQ: MLAB) is listed on Nasdaq, where its shares trade in USD. It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 717 employees.
The shares were at 133.41 USD on 19 November 2026, up 78.8% over 52 weeks. Its 52-week range is 69.51 USD to 144.35 USD: the price is 7.6% below the high and 91.9% above the low.
At a market capitalisation of 749.83M USD, it trades at 115.0 times trailing earnings and 11.0 times forward earnings. The median trailing P/E of its 19 largest Scientific & Technical Instruments peers is 31.0, a premium of 271% for MLAB. It pays a dividend yielding 0.46% (it pays out 55% of its earnings), against a median of 1.05% among the dividend payers in that peer group.
Mesa Laboratories reports return on equity of 3.6%, an operating margin of 10.4% and revenue up 2.6% year over year.
Its debt exceeds its cash by 125.56M USD, a debt-to-equity ratio of 0.83. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 150.00 USD is 12.4% above the current price. The next earnings report is expected on 3 February 2027.